These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5134260)

  • 1. The behaviour of insulinaemia in patients ith liver cirrhosis after intravenous administration of glucose, tolbutamide and glucagon.
    Kasperska T; Lawecki J; Rogala H; Czyzyk A
    Diabetologia; 1971 Oct; 7(5):391-4. PubMed ID: 5134260
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of tolbutamide and glucagon effects on plasma levels of free amino acids in cirrhotics (author's transl)].
    Brodanová M; Brodan V; Andĕl M; Pechar J; Tomková D
    Cas Lek Cesk; 1977 Sep; 116(39):1217-9. PubMed ID: 922790
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoreactive insulin in the portal and the peripheral venous blood after intravenous tolbutamide administration.
    Erwald R; Hed R; Nygren A; Röjdmark S; Sundblad L; Wiechel KL
    Diabetes; 1971 Oct; 20(10):686-90. PubMed ID: 5110700
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma insulin disturbances in primary hyperparathyroidism.
    Kim H; Kalkhoff RK; Costrini NV; Cerletty JM; Jacobson M
    J Clin Invest; 1971 Dec; 50(12):2596-605. PubMed ID: 5129311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 7. [Types of insulin secretion in diabetes mellitus].
    Verlohren HJ; Vrahimis J; Lohmann D
    Dtsch Z Verdau Stoffwechselkr; 1975; 35(4):183-90. PubMed ID: 1227812
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucagon and glucose tolerance in liver cirrhosis.
    Greco AV; Altomonte L; Ghirlanda G; D'Anna LM; Manna R; Caputo S; Uccioli L
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):337-45. PubMed ID: 2899368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative studies of the oral and intravenous tolbutamide test. II. Determination of glucose, serum-insulin and serum-tolbutamide in normal young subjects].
    Berchtold P; Büber V; Meier V; Felber JP; Keiser G
    Diabetologia; 1971 Apr; 7(2):77-81. PubMed ID: 5581543
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
    Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of tolbutamide and butylbiguanide on the blood sugar level and level of immunoreductive serum insulin after a glucose infusion in healthy subjects (author's transl)].
    Brodan V; Slabochová Z; Brodanová M; Kuhn E
    Cesk Gastroenterol Vyz; 1975 Mar; 29(2):89-93. PubMed ID: 1131869
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.
    Pelkonen R; Kallio H; Suoranta H; Karonen SL
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):496-502. PubMed ID: 7023164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of a rapid intravenous injection of glucose or tolbutamide on plasma-insulin concentration in normal and diabetic subjects.
    Schreuder HB; Schopman W
    Acta Physiol Pharmacol Neerl; 1967 Dec; 14(4):523. PubMed ID: 5582727
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic use of glucagon-induced insulin response. Studies in patients with insulinoma or other hypoglycemic conditions.
    Kumar D; Mehtalia SD; Miller LV
    Ann Intern Med; 1974 Jun; 80(6):697-701. PubMed ID: 4364932
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of plasma/insulin, somatropin and NEFA after intravenous administration of tolbutamide in hepatic cirrhosis].
    Greco AV; Ghirlanda G; Rebuzzi A; Altomonte L; Manna R
    Minerva Med; 1976 Nov; 67(54):3525-32. PubMed ID: 995300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T; Lauridsen UB; Madsen SN; Mogensen P
    Dan Med Bull; 1972 Oct; 19(7):222-6. PubMed ID: 5079926
    [No Abstract]   [Full Text] [Related]  

  • 17. [The cyclic AMP, insulin and glucose responses to glucagon stimulation in patients with liver cirrhosis according to the stage of development ].
    Esteva Díaz F; Ducóns García J; Ceña Lázaro G; Márquez Galván M; Juste Rullo G; Barrao Comps F
    Rev Clin Esp; 1986 Nov; 179(7):347-51. PubMed ID: 3025944
    [No Abstract]   [Full Text] [Related]  

  • 18. Postgastrectomy hypoglycemia: a new look.
    Ricketts HT
    JAMA; 1971 Aug; 217(5):689. PubMed ID: 5109089
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic value of intravenous glucagon test in insulinoma.
    Oneda A; Maruhama Y; Itabashi H; Horigome K; Yanbe A
    Tohoku J Exp Med; 1975 Jul; 116(3):205-11. PubMed ID: 170711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.